跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Levoxel - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Levoxel
Approved
STANDARD
Levoxel
Ildong Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
aa9fbdfaebb697ed
Company
Ildong Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
aa9fbdfaebb697ed
Drug Approval Philippines Name
Levoxel
Product Name
Levoxel
Registration Number
DR-XY47627
Brand Name
Levoxel
Generic Name
Levofloxacin (as Hemihydrate)
Dosage Form
Solution For IV Infusion
Dosage Strength
5mg/mL (750mg/150mL)
Manufacturer
Ildong Pharmaceutical Co., Ltd.
Importer
International Apex Pharmaceuticals, Inc.
Distributor
International Apex Pharmaceuticals, Inc.
Company Detail Path
/organization/ildong-pharmaceutical-co-ltd
Issuance Date
22 December 2021
Expiry Date
22 December 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
aa9fbdfaebb697ed
Type
Standard
Back to Philippines FDA Approvals